申请人:ELI LILLY AND COMPANY
公开号:EP0217530A1
公开(公告)日:1987-04-08
The invention discloses the use as vasodilators of compounds of the formula
wherein:
R1 is hydrogen, C1-C4 alkyl, or
each R2 is independently hydrogen, methyl, or amino;
each R3 is independently hydrogen, -COR7, -CO2R7, or -S(O)nR7;
R4 is hydrogen, methyl, methoxy, halo, nitro, or amino;
R5 is hydrogen, methyl, methoxy, halo, C1-C4 alkylthio;
R6 is hydrogen, halo, C1-C4 alkoxy, C1-C4 alkyl, or nitro;
m is 0, 1, 2, 3. or 4;
Z is O, S, or NH;
three or four of A,, A2, A3, and A4 are CH, and the remaining of A1, A2, A3, and A4, if any, is N:
R, is -alk-(Y-alk-),-Ra, allyl, propargyl, C3-C6 cycloalkyl, phenyl, or phenyl substituted with one to three substituents selected from C1-C4 alkyl, C1-C4 alkoxy, nitro, or halo;
each "alk" is a divalent organic radical derived from a C1-C6 aliphatic hydrocarbon;
Y is -0-, -NH-. or a bond;
t is 0 or 1;
R8 is hydrogen, phenyl, pyridyl, -CN or -NR9R10;
n is 0, 1, or 2; and
R9 and R10 are independently C1-C3 alkyl or benzyl, or when taken together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, or homopiperidino ring, or a pharmaceutically acceptable salt thereof. Certain of the compounds are novel.
本发明公开了式化合物作为血管扩张剂的用途
其中
R1 是氢、C1-C4 烷基或
每个 R2 独立地是氢、甲基或氨基
每个 R3 独立地是氢、-COR7、-CO2R7 或 -S(O)nR7
R4 是氢、甲基、甲氧基、卤素、硝基或氨基;
R5 是氢、甲基、甲氧基、卤代、C1-C4 烷硫基;
R6 是氢、卤素、C1-C4 烷氧基、C1-C4 烷基或硝基;
m 是 0、1、2、3 或 4;
Z 是 O、S 或 NH;
A、A2、A3 和 A4 中的三个或四个是 CH,A1、A2、A3 和 A4 中的其余部分(如有)是 N:
R、是-alk-(Y-alk-)、-Ra、烯丙基、丙炔基、C3-C6 环烷基、苯基或被一至三个选自 C1-C4 烷基、C1-C4 烷氧基、硝基或卤素的取代基取代的苯基;
每个 "烷 "都是二价有机基,由 C1-C6 脂肪族烃衍生而来;
Y 是-0-、-NH-或键;
t 是 0 或 1;
R8 是氢、苯基、吡啶基、-CN 或-NR9R10;
n 是 0、1 或 2;以及
R9 和 R10 独立地为 C1-C3 烷基或苄基,或当它们与所连接的氮原子一起形成吡咯烷基、哌啶基或均哌啶基环时,或其药学上可接受的盐。某些化合物是新型的。